Concepedia

Joe Palandra

JP

Statistics

Publications

25

Citations

1.3K

H-Index

20

Active since

2003

Affiliations

Pfizer (United States)(Current)

Bristol-Myers Squibb (United States)

GlaxoSmithKline (United States)

United States Food and Drug Administration

AstraZeneca (United Kingdom)

Joe Palandra is an author at Pfizer (United States) specializing in pharmacy, pharmacology, and bioanalytical method validation.

Publications per year

2003–2025

25

Publications

25

Breast Cancer Resistance Protein (Bcrp/abcg2) Is a Major Determinant of Sulfasalazine Absorption and Elimination in the Mouse

Hani Zaher, Anis A. Khan, Joe Palandra et al. · Molecular Pharmaceutics · 2006 · 160 citations

, , +11

Breast cancer resistance protein (ABCG2) and drug disposition: intestinal expression, polymorphisms and sulfasalazine as an in vivo probe

Bradley L. Urquhart, Joseph A. Ware, Rommel G. Tirona et al. · Pharmacogenetics and Genomics · 2008 · 138 citations

, , +17

Targeted Disruption of Murine Organic Anion-Transporting Polypeptide 1b2 (oatp1b2/Slco1b2) Significantly Alters Disposition of Prototypical Drug Substrates Pravastatin and Rifampin

Hani Zaher, Henriette E. Meyer zu Schwabedissen, Rommel G. Tirona et al. · Molecular Pharmacology · 2008 · 119 citations · Full text

, , +17

Highly Specific and Sensitive Measurements of Human and Monkey Interleukin 21 Using Sequential Protein and Tryptic Peptide Immunoaffinity LC-MS/MS

Joe Palandra, Alyce L. Finelli, Ming Zhu et al. · Analytical Chemistry · 2013 · 105 citations

, , +15

LC−MS/MS Mediated Absolute Quantification and Comparison of Bile Salt Export Pump and Breast Cancer Resistance Protein in Livers and Hepatocytes across Species

Na Li, Joe Palandra, Olga V. Nemirovskiy et al. · Analytical Chemistry · 2009 · 100 citations

, , +16

1–5 of 25